Corcept Therapeutics
CORT
CORT
223 hedge funds and large institutions have $1.55B invested in Corcept Therapeutics in 2020 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 73 increasing their positions, 83 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% less funds holding
Funds holding: 224 → 223 (-1)
1.06% less ownership
Funds ownership: 78.19% → 77.13% (-1.1%)
12% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 83
Holders
223
Holding in Top 10
5
Calls
$25.1M
Puts
$20.1M
Top Buyers
| 1 | +$16.9M | |
| 2 | +$11.9M | |
| 3 | +$11.3M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$9.58M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.57M |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$8.42M | |
| 3 | -$6.66M | |
| 4 |
AWS
AJ Wealth Strategies
New York
|
-$4.73M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$3.87M |